28 days post-treatment | 56 days post-treatment | |||
---|---|---|---|---|
Group | GBCA | |||
Cerebrum (nmol Gd/g) | ||||
SN rats | 1 | Gadoteridol | 0.304 ± 0.088b2,c3,c4 | 0.132 ± 0.022b2,c3,c4 |
n | 8 | 8 | ||
2 | Gadobutrol | 0.57 ± 0.12b1,c4 | 0.348 ± 0.097b1,c4 | |
n | 8 | 7 | ||
3 | Gadoterate | 0.554 ± 0.074c1,c4 | 0.321 ± 0.064c1,c4 | |
n | 8 | 7 | ||
Healthy rats | 4 | Gadoteridol | 0.087 ± 0.015c1,c2,c3 | 0.053 ± 0.007c1,c2,c3 |
n | 5 | 5 | ||
Cerebellum (nmol Gd/g) | ||||
SN rats | 1 | Gadoteridol | 0.328 ± 0.081b2,b3 | 0.264 ± 0.094b4 |
n | 8 | 8 | ||
2 | Gadobutrol | 0.66 ± 0.23b1,c4 | 0.36 ± 0.10b4 | |
n | 8 | 7 | ||
3 | Gadoterate | 0.63 ± 0.13b1,c4 | 0.278 ± 0.036c4 | |
n | 8 | 7 | ||
Healthy rats | 4 | Gadoteridol | 0.16 ± 0.1c2,c3 | 0.084 ± 0.022b1,b2,c3 |
n | 5 | 5 | ||
Peripheral nerves (nmol Gd/g) | ||||
SN rats | 1 | Gadoteridol | 0.60 ± 0.29c2,c3,a4 | 0.166 ± 0.23a3 |
n | 8 | 7 | ||
2 | Gadobutrol | 3.24 ± 0.81c1,c4 | 0.45 ± 0.22 | |
n | 7 | 6 | ||
3 | Gadoterate | 4.3 ± 1.4c1,c4 | 0.78 ± 0.58a1,c4 | |
n | 8 | 8 | ||
Healthy rats | 4 | Gadoteridol | 0.197 ± 0.035a1,c2,c3 | 0.114 ± 0.028c3 |
n | 5 | 5 |